 |
Equitable Distribution of COVID-19 Vaccines Session 2 -
Wednesday, November 18, 5-6 p.m. ET
|
Meet online with community stakeholders, researchers, and Massachusetts health leaders to discuss how to work together to protect us from COVID-19. Join us for session 2 of a 2-part series to understand how state guidelines for equitable vaccine distribution will be implemented locally to address vaccine hesitancy. We hope you will contribute your ideas! Read More.
|
|
|
|
|
Career Development Award Writing Workshop Series -
Application Due Date: November 16, 2020
|
Are you planning to submit a Career Development Award (K01, K08 or K23)?
Have you assembled mentors and developed a Specific Aims page, but want to ensure that you submit the most competitive application possible? The K Grant Writing Workshopis open to Faculty and accomplished Post-Doctoral Students/Fellows who will be remaining at BUMC. Start Application Here.
|
Early Stage Research Career Development Program -
Application Due Date: November 25, 2020
|
The Early Stage Research Career Development Program will provide a roadmap and targeted guidance for senior post-doctoral fellows and junior faculty (both MD and PhD) committed to launching an independent research career. Start Application Here.
|
COVID-19 Vaccine Hesitancy Application -
Application Due Date: December 01, 2020
|
This funding opportunity encourages researchers to submit a pilot project grant application that will identify, develop, test, evaluate and/or refine strategies in order to advance the preparedness of government agencies, healthcare systems, and community organizations in influencing the support of COVID-19 vaccine distribution among populations at the greatest risk of spread or exposure to the virus. Start Application Here.
|
The BU CTSI Voucher Program -
Accepting Applications on a Rolling Basis
|
The BU CTSI Voucher Program is designed to support the short-term needs of research investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, to generate data for new or ongoing projects and/or to secure fee-based core services for expert consultation services (such as biostatistics & data management) with the ultimate goal of furthering clinical and translational research. Start Application Here.
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
National Cancer Institute (NCI)
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
National Center for Complementary and Integrative Health
|
|
|
|
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
National Institute of Allergy and Infectious Diseases (NIAID)
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed)
National Institute on Drug Abuse (NIDA)
|
|
|
|
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
|
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
Office of Strategic Coordination
|
|
|
|
|
Due: December 10, 2020
Funding: $75,000 per year
Project period: Up to 2 years
Purpose: Support promising independent investigators who are leveraging their existing body of work to conduct basic science, behavioral, clinical, or translational research for lung health.
|
|
|
|
Due: December 1, 2020
Funding: $80,000 per year
Project period: 2 years
Purpose: Provides one early-career investigator with a two-year grant to pursue research, training and clinical experience.
|
|
|
|
|
Due: December 15, 2020
Funding: $150,000 – $500,000
Project period: 3 months – 1 year
Purpose: To better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes
|
|
|
|
Due: December 16, 2020
Funding: Up to $60,000 per year
Project period: 3 years
Purpose: To develop therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FPD.
|
|
|
|
|
NIH Calls on Clinical Researchers to Swiftly Share COVID-19 Results |
NIH is prioritizing the processing of COVID-19 submissions to ClinicalTrials.gov to make the information rapidly available in a matter of days, not weeks. Read More. |
|
|
|
|
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Although most immunocompromised persons effectively clear SARS-CoV-2 infection, this case highlights the potential for persistent infection5 and accelerated viral evolution associated with an immunocompromised state.
|
|
|
|
|
Treatments for People with Early COVID-19 Infection is an Urgent Research Focus
Continued research is needed to refine current treatment candidates and develop new drugs, and treatments will need to be administered easily and made available widely at low cost.
|
|
|
|
|
FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
Bamlanivimab was shown in clinical trials to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to placebo.
|
|
|
|
|
Health Experts Want to Prioritize People
of Color for a Covid-19 Vaccine.
Should people in hard-hit communities of color receive priority access to it, and if so, how should that be done? Read More.
|
|
|
|
|
Hydroxychloroquine Does Not Benefit Adults Hospitalized with COVID-19
"ORCHID shows that hydroxychloroquine does not improve clinical outcomes in hospitalized COVID-19 patients,” said James P. Kiley, Ph.D., director, Division of Lung Diseases at NHLBI. Read More.
|
|
|
|
|
Speeding COVID-19 Drug Discovery with Quantum Dots
These multi-colored orbs in the illustration are actually lab-made nanocrystals called quantum dots. They have been specially engineered to look and, in some ways, act like the coronavirus while helping to solve a real challenge for many labs that would like to study SARS-CoV-2. Read More.
|
|
|
|
|
The Ambitious Effort to Piece Together America's Fragmented Health Data:
The Infrastructure Could Help Fight the Next Pandemic
From the early days of the COVID-19 pandemic, epidemiologist Melissa Haendel knew that the United States was going to have a data problem. Read More.
|
|
|
|
|
All of Us Researcher Onramp Event -
November 12, 2020;
11:00 a.m - 3:00 p.m. EST
The event is geared toward current and prospective Workbench users, trainees, and early-career investigators who have experience with coding or with R/Python and an interest/background in data science.
|
|
|
|
|
AMIA 2020 Virtual Annual Symposium - November 14-18, 2020
This Symposium brings together informatics professionals from diverse backgrounds committed to transforming health through informatics. Read More.
|
|
|
|
|
A Deeper Dive into SciVal: Data and Metrics - November 16, 2020 - 1:00 - 3:00 p.m. EST
Join this workshop for a deeper look into the metrics and tools available through SciVal. Read More.
|
|
|
|
|
2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19 - November 19, 2020 - 1:00 p.m. EST
The seminar will bring together researchers, medical practitioners and others to explore topics in rural health. Learn about the impact
of COVID-19 on rural populations, on systems and workforce issues, and on community engagement in response to the pandemic. Read More.
|
|
|
|
|
BridgeResearch:
A Virtual Informational Event Series - December 1, 2020 ; 4:30 - 5:15p.m. EST
Join the Harvard Catalyst Postgraduate Education program to virtually connect with faculty, staff, and past participants to learn about courses, resources, and other offerings which are open to fellows, trainees, and faculty within and outside Harvard. Read More.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
